Evaxion A (EVAX) Cash from Investing Activities (2020 - 2022)
Evaxion A (EVAX) posted Cash from Investing Activities of -$77000.0 for Q2 2022, up 51.57% on a QoQ basis from -$159000.0 in Q1 2022, and up 90.63% year-over-year from -$40391.8 in Q2 2021.
Evaxion A (EVAX) Cash from Investing Activities (2020 - 2022) Analysis & Trends
Evaxion A's Cash from Investing Activities history runs 3 years deep, the most recent figure standing at -$77000.0 for Q2 2022.
- Quarterly Cash from Investing Activities rose 90.63% year-over-year to -$77000.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was -$2.2 million (down 57.25% YoY) and the FY2025 annual result came in at -$14000.0, down 366.67% from the prior year.
- Cash from Investing Activities was -$77000.0 for Q2 2022 at Evaxion A, up from -$159000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$77000.0 in Q2 2022 and bottomed at -$1.2 million in Q3 2021.
- A 3-year average of -$359500.0 and a median of -$145000.0 in 2020 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2021 — Cash from Investing Activities sank 780.15% — and 2022, when it surged 90.63%.
- Evaxion A's Cash from Investing Activities stood at -$131000.0 in 2020, then sank by 780.15% to -$1.2 million in 2021, then soared by 93.32% to -$77000.0 in 2022.
- Business Quant data shows EVAX's Cash from Investing Activities at -$77000.0 in Q2 2022, -$159000.0 in Q1 2022, and -$1.2 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.67 Bn | 466.88 Bn | 1.35 Bn | -45.51 Mn |
| 5 | Vertex Pharmaceuticals | 122.32 Bn | 115.07 Bn | 2.59 Bn | -431.90 Mn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | -428.90 Mn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.55 Bn | 34.54 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Evaxion A | 1.24 Bn | 1.24 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -77,000.00 |
| Jun 30, 2022 | -77,000.00 |
| Mar 31, 2022 | -159,000.00 |
| Mar 31, 2022 | -159,000.00 |
| Sep 30, 2021 | -1.15 Mn |
| Sep 30, 2021 | -1.15 Mn |
| Jun 30, 2021 | -822,000.00 |
| Jun 30, 2021 | -822,000.00 |
| Mar 31, 2021 | -327,000.00 |
| Mar 31, 2021 | -327,000.00 |
| Sep 30, 2020 | -131,000.00 |
| Sep 30, 2020 | -131,000.00 |
| Jun 30, 2020 | -126,000.00 |
| Jun 30, 2020 | -126,000.00 |
| Mar 31, 2020 | -81,000.00 |
| Mar 31, 2020 | -81,000.00 |